Literature DB >> 11381008

Menopause and hormone replacement: Part 1. Evaluation and treatment.

S Ratner1, D Ofri.   

Abstract

Mesh：

Year:  2001        PMID： 11381008      PMCID： PMC1071429          DOI： 10.1136/ewjm.174.6.400

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  19 in total

Review 1.  Health potential of soy isoflavones for menopausal women.

Authors:  J J Anderson; M S Anthony; J M Cline; S A Washburn; S C Garner
Journal:  Public Health Nutr       Date:  1999-12       Impact factor: 4.022

2.  Treatment of menopausal hot flashes with transdermal administration of clonidine.

Authors:  M Nagamani; M E Kelver; E R Smith
Journal:  Am J Obstet Gynecol       Date:  1987-03       Impact factor: 8.661

3.  The effect of postmenopausal estrogen therapy on bone density in elderly women.

Authors:  D T Felson; Y Zhang; M T Hannan; D P Kiel; P W Wilson; J J Anderson
Journal:  N Engl J Med       Date:  1993-10-14       Impact factor: 91.245

4.  Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.

Authors:  J L Shifren; G D Braunstein; J A Simon; P R Casson; J E Buster; G P Redmond; R E Burki; E S Ginsburg; R C Rosen; S R Leiblum; K E Caramelli; N A Mazer
Journal:  N Engl J Med       Date:  2000-09-07       Impact factor: 91.245

5.  A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.

Authors:  F Grodstein; J E Manson; G A Colditz; W C Willett; F E Speizer; M J Stampfer
Journal:  Ann Intern Med       Date:  2000-12-19       Impact factor: 25.391

6.  Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.

Authors:  D H Upmalis; R Lobo; L Bradley; M Warren; F L Cone; C A Lamia
Journal:  Menopause       Date:  2000 Jul-Aug       Impact factor: 2.953

7.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

8.  Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial.

Authors:  R Strickler; D W Stovall; D Merritt; W Shen; M Wong; S L Silfen
Journal:  Obstet Gynecol       Date:  2000-09       Impact factor: 7.661

9.  A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.

Authors:  R Raz; W E Stamm
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

10.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

Authors:  M J Stampfer; G A Colditz; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.